Treatment of acute lymphoblastic leukemia in a second remission

Donald Pinkel, F. Leonard Johnson, E. Donnall Thomas, A. John Barrett, Brad H. Pollock, George R. Buchanan

Research output: Contribution to journalLetter

4 Scopus citations

Abstract

To the Editor: Barrett et al. (Nov. 10 issue)1conclude that for children with acute lymphoblastic leukemia (ALL) in a second remission, bone marrow transplants from HLA-identical siblings result in fewer relapses and longer leukemia-free survival than does chemotherapy. This conclusion was based on a comparison of children whose cases were reported to the International Bone Marrow Transplant Registry and children treated with chemotherapy by the Pediatric Oncology Group. Their report arouses some concern. The comparison does not take into account possible differences between the two groups with respect to race or ethnic background, financial and nutritional status, and type. . .

Original languageEnglish (US)
Pages (from-to)823-824
Number of pages2
JournalNew England Journal of Medicine
Volume332
Issue number12
DOIs
StatePublished - Mar 23 1995

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Pinkel, D., Johnson, F. L., Thomas, E. D., Barrett, A. J., Pollock, B. H., & Buchanan, G. R. (1995). Treatment of acute lymphoblastic leukemia in a second remission. New England Journal of Medicine, 332(12), 823-824. https://doi.org/10.1056/NEJM199503233321217